Melanoma: Vaccine and pembrolizumab combo may lower recurren

Combining a new vaccine with the immunotherapy pembrolizumab significantly reduced the likelihood of melanoma recurring, according to a new clinical trial.

Related Keywords

Andrewl Pecora , Jeffrey Weber , Trevan Fischer , Santa Monica , Hackensack Meridian Health , Isaac Perlmutter Cancer Center , Medical News , News Today , Saint John , Cancer Institute , Providence Saint John , Health Center ,